Pistol-grip Syringe holder (Cameco syringe pistol) in fine needle aspiration Biopsy: any advantages over the use of direct finger grip?

Autor: AA Mayun, HA Nggada, JO Abdulazeez, AB Musa, UH Pindiga, MIA Khalil

Publikováno v: The Nigerian postgraduate medical journal. 20(2)

The study seeks to determine the advantages of using the pistol-grip syringe holder in the performance of FNAB over the use of direct finger grip method.The skin is cleaned with gauze soaked in methylated spirit and the lump is located and firmly hel

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dea0c8bb5fc44455fb0ca26dc9600c00
https://pubmed.ncbi.nlm.nih.gov/23959352

Prevalence of Preinvasive Lesions of the Cervix in Maiduguri, North-Eastern Nigeria

Autor: U Inuwa, M Bukar, A.A Mayun, AB Musa, B M Audu

Publikováno v: Nigerian Medical Practitioner; Vol 55, No 4 (2009)

Cervical cancer is the leading cause of cancer related mortality in developing countries. The lack of routine cytological screening in developing countries is mainly responsible for this unacceptably high mortality. Early detection of pre-invasive di

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9df7efefcf8463acea55516780681cb
https://doi.org/10.4314/nmp.v55i4.45431

Seroepidemiological Survey on Bluetongue Virus (BTV) among Cattle, Sheep, and Goats in Gadarif State, Eastern Sudan.

Autor: Abraheem HH; Central Veterinary Research Laboratory (CVRL) Animal Resources Research Corporation (ARRC) P.O. Box 8067, El Amarat, Khartoum, Sudan., Hussien MO; Central Laboratory Ministry of Higher Education and Scientific Research P.O. Box 7099, Khartoum, Sudan., Elhassan AM; Central Veterinary Research Laboratory (CVRL) Animal Resources Research Corporation (ARRC) P.O. Box 8067, El Amarat, Khartoum, Sudan., Enan KA; Central Laboratory Ministry of Higher Education and Scientific Research P.O. Box 7099, Khartoum, Sudan., Musa AB; Central Laboratory Ministry of Higher Education and Scientific Research P.O. Box 7099, Khartoum, Sudan., Ahmed SK; Central Veterinary Research Laboratory (CVRL) Animal Resources Research Corporation (ARRC) P.O. Box 8067, El Amarat, Khartoum, Sudan., El Hussein ARM; Central Laboratory Ministry of Higher Education and Scientific Research P.O. Box 7099, Khartoum, Sudan.

Publikováno v: International journal of microbiology [Int J Microbiol] 2024 Sep 18; Vol. 2024, pp. 7712412. Date of Electronic Publication: 2024 Sep 18 (Print Publication: 2024).

Efficacy of tocilizumab in patients with severe COVID-19: Survival and clinical outcomes.

Autor: Al-Baadani A; Infectious Diseases Unit, Prince Sultan Military Medical City, Riyadh, Saudi Arabia., Eltayeb N; Infectious Diseases Unit, Prince Sultan Military Medical City, Riyadh, Saudi Arabia., Alsufyani E; Infectious Diseases Unit, Prince Sultan Military Medical City, Riyadh, Saudi Arabia., Albahrani S; Infectious Diseases Unit, Dhahran General Hospital, Dhahran, Saudi Arabia., Basheri S; Pulmonary Medicine Unit, Prince Sultan Military Medical City, Riyadh, Saudi Arabia., Albayat H; Infectious Disease Unit, Imam Abdulrahman Al Faisal Hospital, Riyadh, Saudi Arabia., Batubara E; Pulmonary Medicine Unit, Prince Sultan Military Medical City, Riyadh, Saudi Arabia., Ballool S; Infectious Disease Unit, Imam Abdulrahman Al Faisal Hospital, Riyadh, Saudi Arabia., Al Assiri A; Infectious Disease Unit, Imam Abdulrahman Al Faisal Hospital, Riyadh, Saudi Arabia., Faqihi F; Infectious Disease Unit, Imam Abdulrahman Al Faisal Hospital, Riyadh, Saudi Arabia., Musa AB; King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia., Robert AA; Department of Endocrinology and Diabetes, Prince Sultan Military Medical City, Saudi Arabia., Alsherbeeni N; Infectious Diseases Unit, Prince Sultan Military Medical City, Riyadh, Saudi Arabia., Elzein F; Infectious Diseases Unit, Prince Sultan Military Medical City, Riyadh, Saudi Arabia. Electronic address: felzein@psmmc.med.sa.

Publikováno v: Journal of infection and public health [J Infect Public Health] 2021 Aug; Vol. 14 (8), pp. 1021-1027. Date of Electronic Publication: 2021 May 31.

Primary prevention of stroke in children with sickle cell anemia in sub-Saharan Africa: rationale and design of phase III randomized clinical trial.

Autor: Abdullahi SU; Department of Pediatrics, Bayero University, Aminu Kano Teaching Hospital, Kano, Nigeria., Wudil BJ; Department of Pediatrics, Hasiya Bayero Specialist Hospital, Kano, Nigeria., Bello-Manga H; Department of Hematology and Blood Transfusion, Barau-Dikko Teaching Hospital, Kaduna, Nigeria., Musa AB; Department of Pediatrics, Bayero University, Aminu Kano Teaching Hospital, Kano, Nigeria., Gambo S; Department of Pediatrics, Murtala Mohammed Specialist Hospital, Kano, Nigeria., Galadanci NA; Department of Epidemiology, School of Public health, University of Alabama at Birmingham, Birmingham, Alabama, USA., Aminu H; Department of Pediatrics, Bayero University, Aminu Kano Teaching Hospital, Kano, Nigeria., Tijjani Gaya A; Department of Pediatrics, Murtala Mohammed Specialist Hospital, Kano, Nigeria., Sanusi S; Department of Community Medicine, Bayero University, Aminu Kano Teaching Hospital, Kano, Nigeria., Tabari MA; Department of Community Medicine, Bayero University, Aminu Kano Teaching Hospital, Kano, Nigeria., Galadanci A; Department of Hematology and Blood Transfusion, Bayero University, Aminu Kano Teaching Hospital, Kano, Nigeria., Borodo A; Department of Medicine, Murtala Mohammed Specialist Hospital, Kano, Nigeria., Abba MS; Department of Pharmacy, Bayero University, Aminu Kano Teaching Hospital, Kano, Nigeria., Dambatta AH; Department of Community Medicine, Bayero University, Aminu Kano Teaching Hospital, Kano, Nigeria., Haliru L; Department of Pediatrics, Kaduna State University, Barau Dikko Teaching Hospital, Kaduna, Nigeria., Gambo A; Department of Pediatrics, Murtala Mohammed Specialist Hospital, Kano, Nigeria., Cassell H; Vanderbilt Institute for Global Health, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Rodeghier M; Rodeghier Consultants, Chicago, Illinois, USA., Ghafuri DL; Department of Pediatrics, Division of Hematology and Oncology, Vanderbilt-Meharry Center of Excellence in Sickle Cell Disease, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Covert Greene BV; Department of Pediatrics, Division of Hematology and Oncology, Vanderbilt-Meharry Center of Excellence in Sickle Cell Disease, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Neville K; Department of Pediatrics, University of Kansas for Medical Sciences, Little Rock, Arkansas, USA., Kassim AA; Department of Pediatrics, Division of Hematology and Oncology, Vanderbilt-Meharry Center of Excellence in Sickle Cell Disease, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Department of Hematology and Oncology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA., Kirkham F; Department of Pediatrics, UCL Great Ormond Street Institute of Child Health, London, UK., Trevathan E; Vanderbilt Institute for Global Health, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Jordan LC; Department of Pediatrics, Division of Pediatric Neurology, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Aliyu MH; Vanderbilt Institute for Global Health, Vanderbilt University Medical Center, Nashville, Tennessee, USA., DeBaun MR; Department of Pediatrics, Division of Hematology and Oncology, Vanderbilt-Meharry Center of Excellence in Sickle Cell Disease, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Publikováno v: Pediatric hematology and oncology [Pediatr Hematol Oncol] 2021 Feb; Vol. 38 (1), pp. 49-64. Date of Electronic Publication: 2020 Nov 25.